Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
21st Sep 2023 3:30 pm RNS Director/PDMR Shareholding
19th Sep 2023 7:00 am RNS Apretude for PrEP receives EMA approval
18th Sep 2023 7:00 am RNS FDA approves Ojjaara (momelotinib)
13th Sep 2023 3:30 pm RNS Director/PDMR Shareholding
11th Sep 2023 3:30 pm RNS Director/PDMR Shareholding
11th Sep 2023 7:00 am RNS Momelotinib filing accepted in Japan
1st Sep 2023 3:00 pm RNS Total Voting Rights
1st Sep 2023 7:00 am RNS GSK’s Nucala CRSwNP submission accepted in Japan
31st Aug 2023 3:16 pm RNS Holding(s) in Company
31st Aug 2023 3:14 pm RNS Holding(s) in Company
25th Aug 2023 3:30 pm RNS Director/PDMR Shareholding
23rd Aug 2023 3:30 pm RNS Director/PDMR Shareholding
23rd Aug 2023 7:00 am RNS Shingrix data demonstrate 100% efficacy in China
22nd Aug 2023 3:30 pm RNS Director/PDMR Shareholding
10th Aug 2023 3:30 pm RNS Director/PDMR Shareholding
9th Aug 2023 3:30 pm RNS Director/PDMR Shareholding
8th Aug 2023 1:05 pm RNS Publication of Base Prospectus
1st Aug 2023 3:00 pm RNS Total Voting Rights
31st Jul 2023 6:00 pm RNS FDA approves new use for Jemperli plus chemo
31st Jul 2023 3:30 pm RNS Director/PDMR Shareholding
28th Jul 2023 3:30 pm RNS Director/PDMR Shareholding
26th Jul 2023 7:00 am RNS 2nd Quarter Results
24th Jul 2023 7:00 am RNS Cabotegravir LA for PrEP receives positive CHMP
20th Jul 2023 3:30 pm RNS Director/PDMR Shareholding
17th Jul 2023 3:30 pm RNS Director/PDMR Shareholding
13th Jul 2023 3:30 pm RNS Director/PDMR Shareholding
3rd Jul 2023 3:00 pm RNS Total Voting Rights
28th Jun 2023 3:43 pm RNS GSK completes acquisition of BELLUS Health
27th Jun 2023 7:00 am RNS FDA Fast Track for Gonorrhoea Vaccine Candidate
26th Jun 2023 7:05 am RNS Shingrix approved in Japan for adults 18 and over
26th Jun 2023 7:00 am RNS GSK daprodustat gains positive EMA CHMP opinion
23rd Jun 2023 3:37 pm RNS Director/PDMR Shareholding
23rd Jun 2023 3:33 pm RNS Director/PDMR Shareholding
23rd Jun 2023 3:30 pm RNS Director/PDMR Shareholding
23rd Jun 2023 7:00 am RNS Statement: Zantac (ranitidine) litigation
22nd Jun 2023 7:00 am RNS GSK’s Arexvy recommended by ACIP
21st Jun 2023 7:00 am RNS Season two data for GSK Arexvy RSV OA vaccine
16th Jun 2023 7:00 am RNS Extension of FDA review period for momelotinib
12th Jun 2023 3:30 pm RNS Director/PDMR Shareholding
7th Jun 2023 7:00 am RNS EU authorisation of GSK’s RSV vaccine Arexvy
FTSE 100 Latest
Value8,975.66
Change108.64